Gazyva 1,000 MG/40 ML vial 40ML
Ended Awarded
- Contract number
- SPE2DX25F6UWR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,321
Award facts
- Contract value 100% obligated
- $14,321.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a $14,321.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 mg/40 ml vials of Gazyva, a monoclonal antibody medication used in oncology and hematology treatments. This non-competitive delivery order, issued on September 12, 2025, is scheduled for completion by October 3, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania location. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a critical federal vendor through competitive procurement processes. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, vaccines, and specialty medications to support military and veteran healthcare systems. This particular delivery order for Gazyva exemplifies the company's role in supplying specialized oncology medications essential to the Defense Health Agency and other government healthcare systems, leveraging its position as a prime vendor under the DLA's comprehensive pharmaceutical supply framework.
Quick answers
Who was awarded contract SPE2DX25F6UWR?
SPE2DX25F6UWR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 12, 2025.
How much is contract SPE2DX25F6UWR worth?
The government has obligated $14,321 on SPE2DX25F6UWR.
Is contract SPE2DX25F6UWR an order under another contract?
Yes. SPE2DX25F6UWR is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UWR competed?
The extent of competition for SPE2DX25F6UWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award